newsfilter
← Latest News
PR Newswire·

Phio Pharmaceuticals Announces Reverse Stock Split

MARLBOROUGH, Mass., Jan. 25, 2023 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ:PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed to make immune